Protein stability measurements amplified: Combining SEC-MALS and DLS to maximize data output
The stability of a protein sample and its tendency to aggregate is explored using a combination of SEC-MALS and DLS
sponsored by Malvern Panalytical
All biopharmaceuticals are subject to extremely high regulatory burdens which must be met to show their efficacy and safety. One particular area of regulatory scrutiny for biologics is their stability and the level of aggregate material that they contain. Tools that can be used to study protein stability and aggregation provide valuable information for regulators and assist developers to produce safe, reliable, high quality products. Using orthogonal technologies for complementary analyses increases confidence in the resulting data.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.